SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹22 Cr | ₹-36 Cr | ₹-121 Cr | ₹41 Cr | ₹95 Cr |
What is the latest Consolidated Net Profit of SEQUENT SCIENTIFIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹-36 Cr |
| Mar2023 | ₹-121 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹95 Cr |
How is Consolidated Net Profit of SEQUENT SCIENTIFIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | Positive | |
| Mar2024 | ₹-36 Cr | Negative | |
| Mar2023 | ₹-121 Cr | Negative | |
| Mar2022 | ₹41 Cr | -57.09 | |
| Mar2021 | ₹95 Cr | - | |
Compare Consolidated Net Profit of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹6,048.1 Cr | 4.7% | 20.5% | 30.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| CIPLA | ₹123,504.0 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 4.7% |
20.5% |
30.5% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses